chondroitin-sulfates and Blast-Injuries

chondroitin-sulfates has been researched along with Blast-Injuries* in 3 studies

Reviews

1 review(s) available for chondroitin-sulfates and Blast-Injuries

ArticleYear
Advances in treating skin defects of the hand: skin substitutes and negative-pressure wound therapy.
    Hand clinics, 2012, Volume: 28, Issue:4

    Surgeons and scientists have been developing alternative methods of hand reconstruction that may play an adjunctive role to, or completely supplant, more traditional reconstructive modalities. This article provides an overview of these emerging techniques, with an emphasis on skin substitutes and negative-pressure wound therapy as they apply to the treatment of soft tissue defects of the hand. The indications, contraindications, and relative advantages and disadvantages of these techniques are discussed in detail.

    Topics: Bandages; Blast Injuries; Chondroitin Sulfates; Coated Materials, Biocompatible; Collagen; Hand Injuries; Humans; Negative-Pressure Wound Therapy; Occlusive Dressings; Plastic Surgery Procedures; Skin, Artificial; Soft Tissue Injuries; Wound Healing

2012

Other Studies

2 other study(ies) available for chondroitin-sulfates and Blast-Injuries

ArticleYear
Application of a collagen-based membrane and chondroitin sulfate-based hydrogel adhesive for the potential repair of severe ocular surface injuries.
    Military medicine, 2014, Volume: 179, Issue:6

    This study was performed to evaluate the potential of a chondroitin sulfate-polyethylene glycol (CS-PEG) adhesive and collagen-based membrane (collagen vitrigel, CV) combination as a method to treat penetrating ocular injuries on the battlefield and to improve this method with two technologies: an antibiotic releasing CS-PEG adhesive and a corneal shaped CV. Burst testing using porcine cadaveric eyes, high-performance liquid chromatography, the Kirby-Bauer bacterial inhibition test, and CV implantations on the live and cadaveric rabbit eyes were performed. The ocular burst test showed CS-PEG adhesive could successfully repair 5-mm to 6-mm length wounds in the corneal and corneoscleral regions but would require CS-PEG + CV to treat larger wounds similar to those seen on the battlefield. In addition, high performance liquid chromatography and the Kirby-Bauer bacterial inhibition test presented evidence suggesting the vancomycin incorporated CS-PEG could inhibit Staphylococcus infection for 9 days. Furthermore, the curved CV showed an advantage by matching the corneal contour without any wrinkle formation. Although this pilot study showed a limited range of possible applications, we demonstrated that the combination of CS-PEG adhesive + CV is a promising method and the 2 technologies improve their applicability to the special demands of the battlefield.

    Topics: Animals; Anti-Bacterial Agents; Blast Injuries; Cadaver; Chondroitin Sulfates; Collagen; Corneal Perforation; Disk Diffusion Antimicrobial Tests; Eye Injuries, Penetrating; Hydrogels; Male; Membranes, Artificial; Polyethylene Glycols; Rabbits; Staphylococcus aureus; Swine; Tissue Adhesives; Vancomycin

2014
Integra™ permits early durable coverage of improvised explosive device (IED) amputation stumps.
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2013, Volume: 66, Issue:12

    Improvised explosive device (IED) blasts cause serious injury. Survivors are left with multiple amputations, considerable soft tissue loss and open fractures with gross contamination. We present our early experience of Integra™ in the acute management of military wounds.. The clinical records of all patients with IED injuries who underwent early reconstruction with Integra™ during the six month period between August and December 2009 in our unit were reviewed and data gathered prospectively.. There were 7 male soldiers, aged 21-31 years (mean=26). All sustained trunk and limb injuries, including multiple amputations. Number of procedures prior to application of Integra™ was 4-10 (mean=5). Application of Integra™ took place 6-24 days post-injury (mean=13). Size of wounds covered with Integra™ was 1-11.5% TBSA (mean=5%). Anatomical sites reconstructed included amputation stumps, and both upper and lower limbs. There was partial take of Integra in 3 wounds in 2 patients. All wounds were eventually treated with delayed split skin grafting and healed satisfactorily.. IEDs produce a large zone of injury with massive soft tissue damage, multiple discontinuous wounds which are significantly contaminated. The physiological insult is equivalent to a large cutaneous burn and there is a paucity of available donor sites. Multiple amputees also have a greater energy and power requirement(1-4) and cannot spare remaining functional muscles as donors. The literature suggests that microvascular flaps have a high failure rate in military patients.(5) Reconstruction began as soon as wounds were considered sufficiently clean. Integra™ was applied with the aim of providing higher quality coverage than that provided by split skin grafting alone (particularly for amputation stumps) whilst minimising operative time and morbidity. Integra™ allows timely closure of battlefield wounds with minimal operative time and morbidity. The procedure can begin whilst still in the acute phase and certainly before one would consider lengthy complex operations such as free flaps. Our experience suggests that Integra™ can allow early closure with robust tissue, promoting early rehabilitation and return to duties.

    Topics: Adult; Afghan Campaign 2001-; Amputation Stumps; Amputation, Traumatic; Arm Injuries; Blast Injuries; Chondroitin Sulfates; Collagen; Explosions; Humans; Leg Injuries; Male; Military Personnel; Skin Transplantation; Skin, Artificial; Soft Tissue Injuries; Young Adult

2013